|
UTI Prophylaxis Using Bacterial Interference Following SCI Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about UTI Prophylaxis Using Bacterial Interference Following SCI conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. UTI Prophylaxis Using Bacterial Interference Following SCI Clinical research trials and UTI Prophylaxis Using Bacterial Interference Following SCI healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as UTI Prophylaxis Using Bacterial Interference Following SCI. UTI Prophylaxis Using Bacterial Interference Following SCI Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a UTI Prophylaxis Using Bacterial Interference Following SCI clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their UTI Prophylaxis Using Bacterial Interference Following SCI condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "U" Clinical Trials Conditions > UTI Prophylaxis Using Bacterial Interference Following SCI  UTI Prophylaxis Using Bacterial Interference Following SCI
UTI Prophylaxis Using Bacterial Interference Following SCI
For Condition: Urinary Tract Infections
Status: Recruiting
Sponsor(s): Department of Veterans Affairs Rehabilitation Research and Development Service ,
Synopsis: Urinary tract infection (UTI) is the most common infection in patients with SCI and is a major cause of morbidity and mortality in this population. The bladder of patients with SCI, especially those who have indwelling catheters, is often colonized by bacteria that may or may not cause symptoms of UTI. Bacteria that do not cause symptoms are usually considered benign colonizers and are often left untreated because they may afford some protection against symptomatic infection with more harmful bacteria. We applied the concept of using benign bacteria to prevent symptomatic infection, so-called bacterial interference, by deliberately colonizing the bladder of patients with SCI with a non-pathogenic prototype of Escherichia coli (strain 83972). The preliminary results of our VA-funded study that compared the rates of symptomatic UTI in patients with SCI while colonized with E. coli 83972 vs. historical rates of symptomatic UTI prior to study enrollment indicated that deliberate colonization of the bladder of patients with SCI with E. coli 83972 is safe and very promising as to its ability to prevent symptomatic UTI. However, before this innovative approach of bacterial interference can be successfully applied in the population of patients with SCI, it is essential to: (A) confirm the ultimate efficacy of bacterial interference by conducting a prospective, randomized, placebo-controlled clinical trial (objective #1); and (B) enhance the practicality of applying this innovative approach in SCI patients by delineating the bacterial and host factors that can promote successful colonization with E. coli 83972 (objectives #2-3).
Details: A prospective, randomized, placebo-controlled clinical trial will be conducted. Patients who had sustained SCI >18 months earlier, suffer from neurogenic bladder (require intermittent bladder catheterization, an indwelling suprapubic catheter, or an external collection device), and have a history of frequent symptomatic UTI (> 2 episodes during the preceding year) will be eligible for enrollment. Exclusion criteria will include urolithiasis, indwelling nephrostomy catheter, indwelling transurethral foley catheter, supravesical urinary diversion, vesicoureteral reflux, conditions anticipated to require antibiotic therapy for chronic recurrent extraurogenital infections (e.g. infected decubitus ulcers), uncontrolled diabetes mellitus and immunosuppression. Patients considered unreliable to pursue adequate follow-up and those incapable of giving informed consent will also be excluded. Subjects will discontinue all measures to suppress UTI for at least two weeks prior to entry into the study. All patients will have a complete history and physical examination, serum creatinine, plain X-ray of the abdomen (KUB), and urine culture immediately prior to entry into the study. Renal ultrasound and urodynamic evaluation of the urinary tract will also be obtained upon study entry unless they have been performed during the preceding year.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Placebo Control, Single Group Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: SCI UTI
Total Enrollment: 40
Location and Contact Information:
Overall Study Official:
DavidWolff, , Program Analysis and Review Section (PARS) VA Rehabilitation Research & Development Service
VAMC *Recruiting*
Houston, Texas,
United States
Recruiting Rabih Darouiche
Additional Information:
Study ID Numbers: B2410;
Study Start Date: January 2001
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00037921
Other Urinary Tract Infections Studies:
1. UTI Prophylaxis Using Bacterial Interference Following SCI
Related Studies:
Other Urinary Tract Infections Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials
UTI Prophylaxis Using Bacterial Interference Following SCI
|
|
|
|
|
|
|
|
